Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Medesis Pharma S.A. ALMDP.PA
$1.96
-$0.02 (-1.01%)
На 18:05, 12 мая 2023
Ключевые показатели
-
Marketcap
8824583.00000000
-
week52high
4.00
-
week52low
1.80
-
Revenue
47297
-
P/E TTM
-3
-
Beta
0.00000000
-
EPS
-0.69000000
-
Last Dividend
0.00000000
-
Next Earnings Date
25 окт 2022 г. в 10:59
Описание компании
Medesis Pharma S.A., a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. Its products include NanoLithium (NP03), a clinical stage development product for the treatment of Alzheimer's disease; NanosiRNA DH for the treatment of Huntington's Disease; NU01 Plutonium and NU02 Cesium decorporation products for nuclear decorporation; a radioprotection drug to treat people irradiated following a civil or military nuclear accident (NP02 – NanoManganese); NanosiRNA COVID-19, an antiviral treatment solution for viral diseases; and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for the treatment of oncology. The company was founded in 2003 and is based in Montpellier, France.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии